KDK-asiakasliittymäseminaari 21.3.2012

Heli Kautosen esitys KDK-asiakasliittymäseminaarissa 21.3.2012 Helsingissä.

Sistema fuzzy para predição do desempenho produtivo de frangos de corte de 1 a 21 dias de idade

Um sistema de inferência fuzzy foi desenvolvido baseado em dados da literatura para predição do consumo de ração, ganho de peso e conversão alimentar de frangos de corte com idade variando de 1 a 21, dias submetidos a diferentes condições térmicas. O sistema fuzzy foi estruturado com base em três variáveis de entrada: idade das aves (semanas), temperatura (°C) e umidade relativa (%) ambientes, sendo que as variáveis de saída consideradas foram: ganho de peso, consumo de ração e conversão alimentar. A inferência foi realizada por meio do método de Mamdani, que consistiu na elaboração de 45 regras e a defuzzificação por meio do método do Centro de Gravidade. Com base nos resultados, ao se compararem os dados da literatura com os obtidos pelo sistema fuzzy proposto, verificou-se desempenho satisfatório na predição das variáveis respostas, com R² da ordem de 0,995; 0,998 e 0,976, respectivamente. O ganho de peso predito pela lógica fuzzy foi validado com dados experimentais de campo, no qual se obteve R² = 0,975, apresentando grande potencial de uso em sistemas de climatização automatizado.

Thermal comfort temperature update for broiler chickens up to 21 days of age

Due to changes in genetics and nutrition, as well as in acclimatization of broiler chickens to the Brazilian climate, temperature values currently accepted as optimal may be outdated. The objective of this research was to update the environment temperatures that characterize the thermal comfort for broilers chickens from one to 21 days of age, under Brazilian production conditions. This research was conducted with 600 COBB birds, which were distributed in five growth chambers maintained at different temperatures during the first three weeks of age. During the experimental period, temperature values were progressively reduced, consisting in five treatments: T2724/21, T30/27/24, T33/30/27, T36/33/30 and T39/36/33. It was observed that the birds maintained in the T30(27-24) treatment presented better performance compared to other environment conditions. Based on the obtained regression models, the environment temperature values that provide greater weighing gain for the broiler chicken growth in the initial period were 31.3, 25.5 and 21.8 ºC, respectively for the first, second and third week of age.

Fuzzy modeling of broiler performance, raised from 1 to 21 days, subject to heat stress

ABSTRACT Given the need to obtain systems to better control broiler production environment, we performed an experiment with broilers from 1 to 21 days, which were submitted to different intensities and air temperature durations in conditioned wind tunnels and the results were used for validation of afuzzy model. The model was developed using as input variables: duration of heat stress (days), dry bulb air temperature (°C) and as output variable: feed intake (g) weight gain (g) and feed conversion (g.g-1). The inference method used was Mamdani, 20 rules have been prepared and the defuzzification technique used was the Center of Gravity. A satisfactory efficiency in determining productive responses is evidenced in the results obtained in the model simulation, when compared with the experimental data, where R2 values ​​calculated for feed intake, weight gain and feed conversion were 0.998, 0.981 and 0.980, respectively.

Hepatectomias: análise crítica retrospectiva de 21 casos

OBJETIVO: Analisar os principais aspectos técnicos e clínicos referentes às ressecções hepáticas realizadas em um período de cinco anos (1994 a 1998). MÉTODO: Estudo retrospectivo de 21 ressecções hepáticas, com ênfase no tipo de ressecção utilizado, o preparo pré-operatório e as complicações do período pós-operatório. Ademais, estabelecer correlações com os dados clínicos e epidemiológicos, bem como os exames complementares mais solicitados, em especial, o exame histopatológico. RESULTADOS: Foram realizadas oito ressecções locais atípicas, quatro segmentectomias, quatro hepatectomias esquerdas, duas hepatectomias direitas, uma lobectomia esquerda, uma trissegmentectomia esquerda e uma trissegmentectomia direita. As ressecções foram indicadas para tratamento de tumores malignos primários do fígado em nove pacientes; tumores benignos em seis pacientes; miscelânea em três pacientes; metástases hepáticas em dois e tumor de via biliar em um paciente. As complicações pós-operatórias ocorreram em sete pacientes (33%), sendo as mais freqüentes o abscesso subfrênico e peritonite e a mortalidade operatória foi de 9,5%. CONCLUSÕES: A cirurgia hepática tem se tornado cada vez mais factível e as complicações pós-operatórias, sob maior controle clínico, têm diminuído bastante a mortalidade.

The spindle assembly checkpoint as a drug target - Novel small-molecule inhibitors of Aurora kinases

Cell division (mitosis) is a fundamental process in the life cycle of a cell. Equal distribution of chromosomes between the daughter cells is essential for the viability and well-being of an organism: loss of fidelity of cell division is a contributing factor in human cancer and also gives rise to miscarriages and genetic birth defects. For maintaining the proper chromosome number, a cell must carefully monitor cell division in order to detect and correct mistakes before they are translated into chromosomal imbalance. For this purpose an evolutionarily conserved mechanism termed the spindle assembly checkpoint (SAC) has evolved. The SAC comprises a complex network of proteins that relay and amplify mitosis-regulating signals created by assemblages called kinetochores (KTs). Importantly, minor defects in SAC signaling can cause loss or gain of individual chromosomes (aneuploidy) which promotes tumorigenesis while complete failure of SAC results in cell death. The latter event has raised interest in discovery of low molecular weight (LMW) compounds targeting the SAC that could be developed into new anti-cancer therapeutics. In this study, we performed a cell-based, phenotypic high-throughput screen (HTS) to identify novel LMW compounds that inhibit SAC function and result in loss of cancer cell viability. Altogether, we screened 65 000 compounds and identified eight that forced the cells prematurely out of mitosis. The flavonoids fisetin and eupatorin, as well as the synthetic compounds termed SACi2 and SACi4, were characterized in more detail utilizing versatile cell-based and biochemical assays. To identify the molecular targets of these SAC-suppressing compounds, we investigated the conditions in which SAC activity became abrogated. Eupatorin, SACi2 and SACi4 preferentially abolished the tensionsensitive arm of the SAC, whereas fisetin lowered also the SAC activity evoked by lack of attachments between microtubules (MTs) and KTs. Consistent with the abrogation of SAC in response to low tension, our data indicate that all four compounds inhibited the activity of Aurora B kinase. This essential mitotic protein is required for correction of erratic MT-KT attachments, normal SAC signaling and execution of cytokinesis. Furthermore, eupatorin, SACi2 and SACi4 also inhibited Aurora A kinase that controls the centrosome maturation and separation and formation of the mitotic spindle apparatus. In line with the established profound mitotic roles of Aurora kinases, these small compounds perturbed SAC function, caused spindle abnormalities, such as multi- and monopolarity and fragmentation of centrosomes, and resulted in polyploidy due to defects in cytokinesis. Moreover, the compounds dramatically reduced viability of cancer cells. Taken together, using a cell-based HTS we were able to identify new LMW compounds targeting the SAC. We demonstrated for the first time a novel function for flavonoids as cellular inhibitors of Aurora kinases. Collectively, our data support the concept that loss of mitotic fidelity due to a non-functional SAC can reduce the viability of cancer cells, a phenomenon that may possess therapeutic value and fuel development of new anti-cancer drugs.